AbbVie Inc. Common Stock (ABBV) stock analysis
ABBV · AbbVie Inc. Common Stock
Latest recorded price: USD 294.65
Model-estimated fair value: USD 221.85. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Drug Manufacturers - General
At $294.65, ABBV trades 32.8% above the model's base-case value of $221.85. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $167.91 in the conservative case and $282.12 in the optimistic case, with a valuation confidence score of 75/100. About 80% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth 1.8%, free cash flow margin 29.1%, ROIC 17.8%. The model flags 1 risk signal for this company.